Pfizer Q3 Net Profit Falls 8%, Misses Estimates; Raises FY EPS Guidance

Pfizer reported Q3 net profit down 8% year-over-year, missing analyst expectations, though revenue was nearly flat at $16.58B, slightly above consensus. The company raised its full-year 2026 adjusted EPS guidance to $2.95-$3.05, signaling confidence in operational momentum despite profit decline. The mixed results suggest margin pressure but improved forward outlook, with market reaction likely focused on guidance raise.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works